{
  "id": 471,
  "text": "427, the overall survival (OS) rates were $9 9 \\%$ and $9 8 \\% ,$ respectively.Although comparable to IA1 microinvasive adenocarcinoma, the IA2 patients received more aggressive therapy.The number of IA1 and IA2 patients managed by conisation, SH, RH, or other procedures (that included trachelectomy, abdominal or vaginal, and parametrectomy, usually after hysterectomy or conisation as the initial procedure) was 102-138 $( 1 2 - 1 7 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 427, the overall survival (OS) rates were $9 9 \\%$ and $9 8 \\% ,$ respectively.Although comparable to IA1 microinvasive adenocarcinoma, the IA2 patients received more aggressive therapy.The number of IA1 and IA2 patients managed by conisation, SH, RH, or other procedures (that included trachelectomy, abdominal or vaginal, and parametrectomy, usually after hysterectomy or conisation as the initial \n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于IA1和IA2宫颈微浸润腺癌患者，治疗方法通常包括以下几种：锥切术（conisation）、选择性宫切除术（SH）、根治性切除术（RH）以及其他手术治疗。这些其他手术可能包括经腹或经阴道的宫颈切除术（trachelectomy）和子宫旁切除术（parametrectomy），通常是在进行子宫切除术或锥切术作为初步程序后进行。对于IA2的患者，通常采用更为具有侵入性的治疗方法以确保更好的疗效和患者的整体生存率。根据具体病情，治疗方案可能会有所不同，医生会综合考虑患者的健康状况、癌症发展程度以及其他因素来制定最佳的治疗策略。",
  "query": "对于IA1和IA2宫颈微浸润腺癌患者，哪些治疗方法常用于管理，包括更具侵入性的治疗方法？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于IA1和IA2宫颈微浸润腺癌患者，哪些治疗方法常用于管理，包括更具侵入性的治疗方法？\n\n<reference text>: 427, the overall survival (OS) rates were $9 9 \\%$ and $9 8 \\% ,$ respectively.Although comparable to IA1 microinvasive adenocarcinoma, the IA2 patients received more aggressive therapy.The number of IA1 and IA2 patients managed by conisation, SH, RH, or other procedures (that included trachelectomy, abdominal or vaginal, and parametrectomy, usually after hysterectomy or conisation as the initial procedure) was 102-138 $( 1 2 - 1 7 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于IA1和IA2宫颈微浸润腺癌患者，治疗方法通常包括以下几种：锥切术（conisation）、选择性宫切除术（SH）、根治性切除术（RH）以及其他手术治疗。这些其他手术可能包括经腹或经阴道的宫颈切除术（trachelectomy）和子宫旁切除术（parametrectomy），通常是在进行子宫切除术或锥切术作为初步程序后进行。对于IA2的患者，通常采用更为具有侵入性的治疗方法以确保更好的疗效和患者的整体生存率。根据具体病情，治疗方案可能会有所不同，医生会综合考虑患者的健康状况、癌症发展程度以及其他因素来制定最佳的治疗策略。"
}